Anic Equity¶
'#---------------------------------------------------------#'
Total return since start: 0.71 %¶
'#---------------------------------------------------------#'
Equity now: -----------------------------> 52232.29 Kr¶
Max Equity ever reached: ------------> 53120.35 Kr¶
Portfolio value: --------------------------> 45897.26 Kr¶
PnL: ---------------------------------------> -855.74 Kr¶
DD now: ---------------------------------> -1.672 %¶
Max portfolio DD since start: ----> -13.025 %¶
Updated:¶
'2023-06-13 11:35:47.072810'
Anic Portfolio Holdings¶
| volume | changePercent | value | profit | profitPercent | acquiredValue | |
|---|---|---|---|---|---|---|
| name | ||||||
| Nederman Holding | 11 | 3.400000 | 2343.000000 | 154.000000 | 7.040000 | 2189.000000 |
| BHG Group | 49 | -2.390000 | 680.120000 | 41.120000 | 6.440000 | 638.999984 |
| Embracer Group B | 26 | 1.040000 | 681.070000 | 19.070000 | 2.880000 | 661.999988 |
| Biotage | 4 | 0.450000 | 621.200000 | 18.200000 | 3.020000 | 603.000000 |
| Indutrade | 5 | 1.980000 | 1336.500000 | 16.500000 | 1.250000 | 1320.000000 |
| Addtech B | 3 | 1.790000 | 715.800000 | 15.800000 | 2.260000 | 699.999999 |
| SynAct Pharma | 9 | -2.270000 | 658.800000 | 13.800000 | 2.140000 | 645.000003 |
| Eastnine | 6 | -2.960000 | 669.600000 | 12.600000 | 1.920000 | 657.000000 |
| Xvivo Perfusion | 3 | 0.000000 | 856.500000 | 11.500000 | 1.360000 | 845.000001 |
| Nolato B | 12 | -0.090000 | 657.600000 | 9.600000 | 1.480000 | 648.000000 |
| Sdiptech B | 3 | 0.220000 | 831.000000 | 9.000000 | 1.090000 | 822.000000 |
| Addnode Group B | 6 | 1.360000 | 759.600000 | 7.600000 | 1.010000 | 751.999998 |
| Vitrolife | 3 | 1.240000 | 684.000000 | 7.000000 | 1.030000 | 677.000001 |
| BONESUPPORT HOLDING | 10 | -0.320000 | 1229.000000 | 5.000000 | 0.410000 | 1224.000000 |
| Latour B | 2 | 1.480000 | 452.600000 | 3.600000 | 0.800000 | 449.000000 |
| NCC B | 7 | -0.270000 | 656.950000 | 2.950000 | 0.450000 | 653.999997 |
| Fortnox | 10 | 3.520000 | 669.800000 | 1.800000 | 0.270000 | 668.000000 |
| NCC A | 6 | 1.840000 | 598.800000 | -0.200000 | -0.030000 | 598.999998 |
| Sedana Medical | 135 | -2.320000 | 4328.100000 | -2.900000 | -0.070000 | 4330.999935 |
| Profoto Holding | 7 | -0.480000 | 578.200000 | -3.800000 | -0.650000 | 581.999999 |
| Lime Technologies | 2 | -1.350000 | 586.000000 | -7.000000 | -1.180000 | 593.000000 |
| Volati | 5 | -4.550000 | 566.000000 | -8.000000 | -1.390000 | 574.000000 |
| Sampo Oyj SDB | 1 | -1.200000 | 496.000000 | -9.000000 | -1.780000 | 505.000000 |
| Investor B | 3 | 0.420000 | 648.300000 | -9.700000 | -1.470000 | 657.999999 |
| SCA A | 4 | -0.680000 | 586.400000 | -12.600000 | -2.100000 | 599.000000 |
| Humana | 40 | 1.490000 | 652.800000 | -21.200000 | -3.150000 | 674.000000 |
| Balco Group | 39 | -1.360000 | 1834.950000 | -40.050000 | -2.140000 | 1874.999997 |
| Ambea | 68 | 1.330000 | 2491.520000 | -45.480000 | -1.790000 | 2537.000032 |
| Lundin Gold | 7 | 0.920000 | 918.400000 | -55.600000 | -5.710000 | 973.999999 |
| Creades A | 7 | 1.610000 | 550.550000 | -60.450000 | -9.890000 | 610.999998 |
| Investor A | 16 | 0.370000 | 3468.800000 | -76.200000 | -2.150000 | 3545.000000 |
| Gaming Innovation Group | 161 | 0.400000 | 4057.200000 | -130.800000 | -3.120000 | 4187.999942 |
| New Wave B | 40 | -1.020000 | 3780.000000 | -136.000000 | -3.470000 | 3916.000000 |
| Wästbygg Gruppen B | 80 | -1.470000 | 2688.000000 | -183.000000 | -6.370000 | 2871.000000 |
| Bactiguard Holding B | 37 | -3.620000 | 2564.100000 | -402.900000 | -13.580000 | 2966.999993 |
| TOTAL | 45897.260000 | -855.740000 | -1.67179% | 46752.999863 |
Updated:¶
'2023-06-13 11:36:04.800088'
None
Last optimization/rebalancing:¶
'2023-05-05'
Next optimization/rebalancing:¶
'2023-06-15'
AVAN-Live vs backtest and OMXSE30 2023¶
Walk forward test results - depending on starting day¶
Equity is shown as log of returns. Returns range by a factor of 10. Best is about 10000%, 100 times money, and worst 1000%, 10 times money in 20 years. Maximal duration for drawdown periods vary between 280-750 days. Worst drawdown across the tests is about 40 %. ¶
